A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T

NCT05468190 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
48
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Chongqing Precision Biotech Co., Ltd